VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial
Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
“Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease,” Nathan D Mathewson et al., Nature Immunology (2016)
“MDSINE: Microbial Dynamical Systems Inference Engine for microbiome time-series analyses,” Vanni Bucci et al., Genome Biology (2016)
“Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells,” Koji Atarashi et al., Cell (2015)
“Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells,” Yukihiro Furusawa et al., Nature (2013)
“Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota,” Koji Atarashi et al., Nature (2013)
“Induction of colonic regulatory T cells by indigenous Clostridium species,” Koji Atarashi et al., Science (2011)
